You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Treatment for Urinary Tract Infection After Midurethral Sling: A Retrospective Study Comparing Patients Who Receive Short-Term Postoperative Catheterization and Patients Who Pass a Void Trial on the Day of Surgery

Dieter, Alexis A. MD; Amundsen, Cindy L. MD; Visco, Anthony G. MD; Siddiqui, Nazema Y. MD, MHSc

Female Pelvic Medicine & Reconstructive Surgery:
doi: 10.1097/SPV.0b013e3182544e03
Original Articles
Abstract

Introduction: This is a retrospective cohort study comparing the risk of treatment for postoperative urinary tract infection (UTI) in patients who receive short-term postoperative catheterization versus those who pass a void trial on the day of surgery after midurethral sling with or without concomitant pelvic surgery.

Materials and Methods: We compared two cohorts to determine our primary outcome: treatment for UTI, culture proven or empiric, within three weeks after surgery.

Results: 138 patients, were included in the study of which 80 (58%) received postoperative catheterization. The baseline characteristics of the catheterized and noncatheterized groups were similar except that the catheterized group had a lower mean body mass index (28 ± 5 vs 30 ± 5 kg/m2; P = 0.01), were more likely to have undergone concomitant pelvic surgery (51% vs 20%; P < 0.01), had higher estimated blood loss (92 ± 87 vs 47 ± 49 mL; P < 0.01), and had longer operative times (108 ± 75 vs 62 ± 47 min; P < 0.01). Overall, 19.6% of the patients received treatment for UTI. Patients in the catheterized group were more likely to receive treatment for UTI (24/80 [30%] catheterized vs 3/58 [5%] noncatheterized; P < 0.01). This significant difference in treatment for UTI persisted when examining patients who underwent midurethral sling only without concomitant pelvic surgery (6/29 [20.7%] catheterized vs 1/38 [2.6%] noncatheterized; P = 0.04). In a logistic regression model adjusting for age, body mass index, concomitant surgery, and postoperative catheterization, only postoperative catheterization remained significantly associated with treatment for UTI (OR, 6.6; 95% confidence interval, 1.8–24.5; P < 0.01).

Conclusions: Treatment for postoperative UTI is significantly higher in patients who receive short-term postoperative catheterization after midurethral sling with or without concomitant pelvic surgery.

In Brief

This is a retrospective cohort study of patients undergoing midurethral sling with or without concomitant pelvic surgery comparing the risk of treatment of UTI in patients receiving short-term postoperative catheterization compared to patients who pass a void trial on the day of surgery.

Author Information

From the Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC.

Reprints: Alexis A. Dieter, MD, Duke University Medical Center, Box 3616, Durham, NC 27710. E-mail: alexis.dieter@duke.edu.

No funds were received for this research. The authors do not have any associations (commercial or otherwise) that pose a conflict of interest with the submitted material.

© 2012 by Wolters Kluwer Health | Lippincott Williams & Wilkins